Fermentalg

Capital/Financing Update • Jan 20, 2015

Annual report on the liquidity contract entered into with brokerage firm Gilbert Dupont

Press release – Libourne – 20 January 2015 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has published the annual report on its liquidity contract.

Under the liquidity contract granted by Fermentalg to brokerage firm Gilbert Dupont, the following assets appeared on the liquidity account as at 31 December 2014:

• Number of shares: 36,632
• Cash balance: €174,692.22

At the time of the half-yearly report dated 30 June 2014, the following assets appeared on the liquidity account:

• Number of shares: 30,611
• Cash balance: €226,976.50

About Fermentalg

Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health, green chemistry and energy. Fermentalg has already signed its 1st industrial and commercial joint-venture for the production of Omega-3 oils rich in EPA and DHA as well as several other partnerships with leading industrial groups. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.

Fermentalg Fermentalg Pierre Calleja Paul Michalet

Tel: +33 (0)5 57 25 02 20 Tel: +33 (0)5 57 25 79 76

ACTUS finance & communication Alexandra Prisa Tel: +33 (0)1 53 67 35 79 aprisa@actus.fr

Press Relations: Investor Relations:

Chairman and CEO Chief Finance, Strategy & Business Officer pcalleja@fermentalg.com pmichalet@fermentalg.com

ACTUS finance & communication Jérôme Fabreguettes-Leib Tel: +33 (0)1 77 35 04 36 jfl@actus.fr